AstraZeneca (AZN)

Share price graph

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4580.50p Today's change: +1.10%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4580.50p 5 day change: -0.91%

All market data carried by City A.M. is provided by Digital Look. Neither City A.M. nor Digital Look accept any responsibility for the data’s accuracy or usage. Data is delayed by at least 15 minutes and closing prices may not be accurate at market close time.

Price: 4580.50p 6 month change: -0.07%

Contact details

Address: 2 Kingdom Street, London
Phone: +44 (0)20 7604 8000
Fax: +44 (0)20 7604 8151
Website: www.astrazeneca.com

Company information

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

London's top share index hit a fresh all-time high yesterday, setting a record for the longest winning streak [...]

11 January 2017
Shares
15
Views
303

2016's events made fools of most pundits, and looking back at my column exactly a year ago, I fared little better. [...]

6 January 2017
Shares
9
Views
1,136

Pharmaceutical giant AstraZeneca has bagged $550m (£446m) in an initial payment from the sale of its late-stage [...]

23 December 2016
Shares
7
Views
409

AstraZeneca's biological arm MedImmune and US life sciences group Abpro have joined forces on a new research [...]

30 November 2016
Shares
1
Views
175

FTSE 100 pharma firm Hikma has cut its full-year sales guidance for its US generics business to roughly $600m, [...]

10 November 2016
Views
361

AstraZeneca posted weak quarterly profits this morning, but big pharma companies are expected to benefit from [...]

10 November 2016
Views
136

Pharmaceutical stocks – one of the few sectors that was thought to be privately if not publicly hoping for a [...]

9 November 2016
Shares
2
Views
547

Drug giant AstraZeneca, which reports its third quarter results on Thursday, is expected to remain under pressure [...]

6 November 2016
Shares
1
Views
323

Pharmaceuticals bosses are set to meet with ministers next month in a bid to press their case for government support [...]

30 October 2016
Shares
2
Views
487

Drug giant AstraZeneca has struck a deal with Ireland-based pharma firm Allergan to licence a treatment for [...]

3 October 2016
Views
181

The NHS watchdog is drawing up plans to start charging companies fees to get new drugs approved. [...]

2 October 2016
Shares
1
Views
131

Shares in Cambridge-based pharma firm Sareum have shot up by 130 per cent after it announced its up-coming cancer [...]

27 September 2016
Views
198

Big pharma firm AstraZeneca has been forced to withdraw a marketing application for a new cancer drug, due [...]

21 September 2016
Views
162

Some of the world's biggest pharma firms have pledged to crack down on pollution and curb overuse of antibiotics.  [...]

20 September 2016
Shares
1
Views
100

AstraZeneca will pay $5.5m (£4.1m) to resolve a foreign bribery probe in the US. [...]

31 August 2016
Shares
4
Views
109

Content tagged with "AstraZeneca"